PRE
Prenetics Global Ltd
NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH
$16.71
-4.02% today
Updated 2026-04-30
Market cap
$310.15M
P/E ratio
—
P/S ratio
3.36x
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$5 – $24
Volume
0.2M
Prenetics Global Ltd (PRE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |